Japanese Journal of Head and Neck Cancer最新文献_第4页

Utility of ultrasound sonography to assess the upward distance moved by the hyoid bone during saliva swallowing: a study of healthy volunteers 利用超声评估舌骨在吞咽唾液时向上移动的距离:一项健康志愿者的研究

Japanese Journal of Head and Neck Cancer Pub Date : 2022-01-01 DOI: 10.5981/jjhnc.48.351

Keiko Yanai, Junpei Ito, M. Nakahira, Yuichiro Enoki, M. Sugasawa

引用次数: 0

Real world evidence of nivolumab in Japanese patients with head and neck cancer nivolumab用于日本头颈癌患者的真实世界证据

Japanese Journal of Head and Neck Cancer Pub Date : 2022-01-01 DOI: 10.5981/jjhnc.48.1

A. Homma, Hirokazu Kaneko, Toshimitsu Endo

引用次数: 0

Sentinel node navigation surgery as a diagnosis and treatment tool to find occult metastasis for early oral cancer 前哨淋巴结导航手术作为发现早期口腔癌隐匿转移的诊疗工具

Japanese Journal of Head and Neck Cancer Pub Date : 2022-01-01 DOI: 10.5981/jjhnc.48.257

T. Matsuzuka, Y. Hasegawa

引用次数: 0

A rare case of intravascular solitary fibrous tumor from the internal jugular vein to the sigmoid sinus 一例罕见的从颈内静脉到乙状窦的血管内孤立性纤维性肿瘤

Japanese Journal of Head and Neck Cancer Pub Date : 2022-01-01 DOI: 10.5981/jjhnc.48.40

M. Masuda, Y. Honda, Daizo Murakami, Y. Orita

{"title":"A rare case of intravascular solitary fibrous tumor from the internal jugular vein to the sigmoid sinus","authors":"M. Masuda, Y. Honda, Daizo Murakami, Y. Orita","doi":"10.5981/jjhnc.48.40","DOIUrl":"https://doi.org/10.5981/jjhnc.48.40","url":null,"abstract":"We report a rare case of intravascular solitary fibrous tumor （SFT） from the internal jugular vein to the sigmoid sinus, which has been followed over nine years. A 51-year-old woman was referred to our hospital, pre-senting with fullness of the right ear and swelling of the right neck. On imaging study, a tumor occupying from the right supraclavicular to the skull base, through the jugular foramen was found. The biopsy specimen of the intravascular tumor of the right jugular vein was initially diagnosed as epithelioid hemangioendothelioma （EHE）. The tumor increased in size at first, and after two courses of S-1 therapy （Tegafur, a prodrug of 5-ﬂuorouracil, and 5-chloro-2-4-dihydroxypyridine）, the intravascular tumor in the right jugular vein had disappeared, whereas the lesion at the skull base remained stationary. This remaining lesion had gradually enlarged over the next 3—4 years, causing Ⅶ—Ⅻ cranial nerve paralysis. Radiation therapy was administered, and arytenoid adduc-tion and nerve-muscle pedicle ﬂap implantation were performed for laryngeal paralysis. Over 5-year follow-up observation after irradiation, the remaining lesion at the skull base gradually diminished each year. Afterward, the histopathological findings of the biopsy specimen were reviewed and a revised diagnosis of intravascular SFT was made. Intravascular SFT is extremely rare, and the eﬀects of chemotherapy or radiotherapy for a malignant soft tissue tumor are controversial, however, S-1 therapy and radiation therapy were successful in this case.","PeriodicalId":38497,"journal":{"name":"Japanese Journal of Head and Neck Cancer","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71244051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

ERAS protocol for head and neck surgery and quality assessment of postoperative recovery 头颈外科ERAS方案及术后恢复质量评估

Japanese Journal of Head and Neck Cancer Pub Date : 2022-01-01 DOI: 10.5981/jjhnc.48.268

S. Fujimoto, T. Shinozaki, Toshifumi Tomioka, W. Okano, Y. Morishita, R. Hayashi, K. Matsuura

{"title":"ERAS protocol for head and neck surgery and quality assessment of postoperative recovery","authors":"S. Fujimoto, T. Shinozaki, Toshifumi Tomioka, W. Okano, Y. Morishita, R. Hayashi, K. Matsuura","doi":"10.5981/jjhnc.48.268","DOIUrl":"https://doi.org/10.5981/jjhnc.48.268","url":null,"abstract":"Enhanced Recovery After Surgery （ERAS） is a package of various evidence-based perioperative management methods that enhance the quality of postoperative recovery. The Japanese version of the Quality of Recovery score （QoR-40J） is a clinical outcome which is widely used to evaluate the quality of recovery after surgery under general anesthesia. We evaluated the quality of recovery using the QoR-40J in 10 patients who had been managed according to our ERAS protocol for head and neck surgery followed by free tissue transfer reconstruction. We were able to conduct the ERAS protocol safely and to obtain QoR-40J scores in all patients. The mean overall score of QoR-40J signiﬁcantly decreased from the day before surgery to postoperative-day （POD） 1, and tended to recover gradually from POD 2 to POD 7. It was suggested that the score trends of QoR-40J reﬂected the quality of recovery after head and neck surgery followed by free tissue transfer reconstruction. We would like to use the QoR-40J as an indicator to improve perioperative management and to construct a new standard of the ERAS protocol for head and neck surgery.","PeriodicalId":38497,"journal":{"name":"Japanese Journal of Head and Neck Cancer","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71244065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Usefulness of clinical pathway in weight loss reduction during chemoradiotherapy for head and neck cancer 临床路径在头颈癌放化疗减重中的作用

Japanese Journal of Head and Neck Cancer Pub Date : 2021-01-01 DOI: 10.5981/jjhnc.47.303

Makiko Kodani, S. Koyama, Tsuyoshi Morisaki, T. Fukuhara, K. Fujiwara, H. Takeuchi, H. Kataoka

{"title":"Usefulness of clinical pathway in weight loss reduction during chemoradiotherapy for head and neck cancer","authors":"Makiko Kodani, S. Koyama, Tsuyoshi Morisaki, T. Fukuhara, K. Fujiwara, H. Takeuchi, H. Kataoka","doi":"10.5981/jjhnc.47.303","DOIUrl":"https://doi.org/10.5981/jjhnc.47.303","url":null,"abstract":"Chemoradiotherapy for head and neck cancer （HNC） causes various adverse events, among which weight loss is a major concern. Methodologies for the prevention and care of adverse events have not yet been standardized; therefore, we created a clinical pathway （CP） as a tool for standardized assessment and care. In this study, we assessed whether CP is useful in weight loss reduction during chemoradiotherapy for HNC. We retrospectively analyzed 108 patients who underwent treatment with high-dose cisplatin concurrent with radiotherapy （CRT） and cetuximab concurrent with radiotherapy （BRT） from January 2014 to March 2020. We stratiﬁed the patients into those with and without a CP. In CRT, the maximum weight loss rate was not signiﬁcantly reduced in the CP-use group; however, aggravation of oral mucositis was suppressed in the CP-use group （p ＝ 0.043）. In BRT, the maximum weight loss rate was signiﬁcantly reduced in the CP-use group compared with the non-use group （p ＝ 0.011）, and oral mucositis was equally suppressed in the CP-use group （p ＝ 0.037）. We believe that in BRT, using CP is eﬀective in the weight loss reduction that occurs during the treatment.","PeriodicalId":38497,"journal":{"name":"Japanese Journal of Head and Neck Cancer","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71243521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Investigation of parotid gland cancer surgery that preserved the facial nerve 腮腺癌手术保留面神经的探讨

Japanese Journal of Head and Neck Cancer Pub Date : 2021-01-01 DOI: 10.5981/jjhnc.47.316

Ryoki Hamabata, N. Mukoyama, N. Nishio, T. Maruo, M. Hiramatsu, S. Yokoi, M. Sone, Yasushi Fujimoto

{"title":"Investigation of parotid gland cancer surgery that preserved the facial nerve","authors":"Ryoki Hamabata, N. Mukoyama, N. Nishio, T. Maruo, M. Hiramatsu, S. Yokoi, M. Sone, Yasushi Fujimoto","doi":"10.5981/jjhnc.47.316","DOIUrl":"https://doi.org/10.5981/jjhnc.47.316","url":null,"abstract":"要旨顔面神経を温存した耳下腺癌手術症例の,術後の顔面神経麻痺の推移と予後の関係を検討した報告は少ない。当科の耳下腺癌の治療方針は,術前から顔面神経麻痺がある場合は神経合併切除と一期的再建,麻痺がない場合は組織型にかかわらず原則温存としている。過去 15 年間の顔面神経を温存した耳下腺癌手術症例 31 例について検討した。観察期間中央値は 60 ヶ月,全摘 24 例,葉切除が 7 例であった。手術直後の顔面神経麻痺スコアは平均 24 点,中央値は 27 点であった。術後顔面神経麻痺の推移は,一過性に完全麻痺の症例もあったが,最終的に平均 39.5 点まで回復した。回復期間は多くの症例が術後 6 ヶ月までに回復した。治療成績は,5 年全生存率・5 年無病生存率・局所制御率それぞれ 96.0%・89.5%・93.5%と良好な結果であった。術前顔面神経麻痺のない耳下腺癌症例は,病理型に関わらず神経を温存しても治療成績は担保されると考える。","PeriodicalId":38497,"journal":{"name":"Japanese Journal of Head and Neck Cancer","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71243548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prospective observational study of patients treated with carbon-ion radiotherapy for non-squamous cell carcinoma of the head and neck in Gunma University 群马大学碳离子放疗治疗头颈部非鳞状细胞癌患者的前瞻性观察研究

Japanese Journal of Head and Neck Cancer Pub Date : 2021-01-01 DOI: 10.5981/JJHNC.47.53

A. Musha, Nobuteru Kubo, N. Okano, T. Kaminuma, H. Kawamura, Hiro Sato, Y. Takayasu, M. Shino, O. Nikkuni, Shota Ida, K. Shirai, J. Saitoh, M. Ogawa, S. Yokoo, K. Chikamatsu, T. Ohno

{"title":"Prospective observational study of patients treated with carbon-ion radiotherapy for non-squamous cell carcinoma of the head and neck in Gunma University","authors":"A. Musha, Nobuteru Kubo, N. Okano, T. Kaminuma, H. Kawamura, Hiro Sato, Y. Takayasu, M. Shino, O. Nikkuni, Shota Ida, K. Shirai, J. Saitoh, M. Ogawa, S. Yokoo, K. Chikamatsu, T. Ohno","doi":"10.5981/JJHNC.47.53","DOIUrl":"https://doi.org/10.5981/JJHNC.47.53","url":null,"abstract":"of the head and neck in 35 patients enrolled in a pective study at the Gunma University Heavy Ion Medical Center （from 2010 to 2014）. The median age of the patients was 59 years （range, 31-77 years）. The median follow-up time for all the patients was 65 months （range, 6.1-98.8 months）. Thirty-two and three patients received 64.0 Gy （relative biological eﬀectiveness） and 57.6 Gy （relative biological eﬀectiveness） in 16 fractions, respectively. The T-classification was 5/8/22 in T2/3/4, respectively, and the tumors were inoperable in 20 cases （57％）. The maxillary sinus and nasal cavity were the most common sites for tumors in 9 cases （26％）. Adenoid cystic carcinoma was dominant, with this carcinoma being found in 21 cases （60％）. The 5-year local control, progression-free survival, and overall survival rates were 74.5％, 53.2％, and 81.3％, respectively. Nine patients had local recurrence, and six patients died. Acute and late adverse events were evaluated according to the Common Terminology Criteria for Adverse Events, version 4.0. Over acute grade 3 radiation mucositis （8 cases） improved immediately with conservative therapy. Late grade 4 adverse events were observed; these were two cases of visual loss and one case of brain necrosis. There were no grade 5 adverse events. Carbon-ion radiotherapy achieved excellent local control and overall survival rates for non-squamous cell carcinoma.","PeriodicalId":38497,"journal":{"name":"Japanese Journal of Head and Neck Cancer","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71243582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Head and neck reconstruction surgery with microvascular free tissue transfer performed by head and neck surgeons 由头颈部外科医生进行的微血管游离组织移植头颈部重建手术

Japanese Journal of Head and Neck Cancer Pub Date : 2021-01-01 DOI: 10.5981/JJHNC.47.15

T. Matsuki, S. Miyamoto, K. Kano, Shohei Tsutsumi, Ayako Furuki, Kaho Momiyama, Y. Harada, T. Yamashita

{"title":"Head and neck reconstruction surgery with microvascular free tissue transfer performed by head and neck surgeons","authors":"T. Matsuki, S. Miyamoto, K. Kano, Shohei Tsutsumi, Ayako Furuki, Kaho Momiyama, Y. Harada, T. Yamashita","doi":"10.5981/JJHNC.47.15","DOIUrl":"https://doi.org/10.5981/JJHNC.47.15","url":null,"abstract":"要旨遊離組織による再建術は,頭頸部癌切除後の治癒,形態,機能温存において有用である。遊離組織採取と縫い付け,顕微鏡下血管吻合は形成外科医が施行するのが一般的だが,当科では空腸の採取を除き 2017 年 4 月から頭頸部外科医が行っている。2019 年 9 月までの 40 例(41 皮弁)に対し,主に周術期に関する後方視的検討を行った。原発巣は舌が 16 例,下咽頭が 12 例と多く,ほぼ全例が進行癌であった。切除術は咽頭喉頭頸部食道全摘出術が 13 例,舌亜全摘出術が 7 例と続いた。再建材料は空腸が 12 例,前外側大腿皮弁が 11 例と多く,上甲状腺動脈と内頸静脈への吻合が大半を占めた。術時間と出血量の中央値はそれぞれ 603.5 分,517.5ml であった。術中トラブルは 5 例で生じた。術後合併症は 17 例,再手術が 3 例あったが,吻合部血栓による皮弁壊死や縫合不全はなかった。改善点はあるが,過去の報告と比較しても劣らない成績であった。","PeriodicalId":38497,"journal":{"name":"Japanese Journal of Head and Neck Cancer","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71242847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A case of laryngeal adenosquamous carcinoma manifesting as a submucosal tumor 喉腺鳞癌表现为粘膜下肿瘤1例

Japanese Journal of Head and Neck Cancer Pub Date : 2021-01-01 DOI: 10.5981/jjhnc.47.395

Dai Hashimoto

引用次数: 0